Cybin Inc. (CYBN.NE)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Eric So L.L.B. | Co-Founder, President & Executive Chairman | 732k | -- | 1976 |
| Mr. Douglas L. Drysdale | Chief Executive Officer | 1.04M | -- | 1970 |
| Mr. Paul Glavine | Co-Founder, Chief Growth Officer & Director | 732k | -- | 1989 |
| Mr. Greg Cavers | Chief Financial Officer | 450k | -- | 1971 |
| Mr. Aaron Bartlone | Chief Operating Officer | 619.91k | -- | 1967 |
| Mr. George Tziras | Chief Business Officer & Director | -- | -- | 1981 |
| Mr. John Kanakis | Co-Founder | 957.36k | -- | 1981 |
| Dr. Alex L. Nivorozhkin Ph.D. | Chief Scientific Officer | -- | -- | 1960 |
| Ms. Lori Challenger | Chief Compliance, Ethics & Administrative Officer | -- | -- | -- |
| Mr. Gabriel Fahel | Chief Legal Officer & Corporate Secretary | -- | -- | 1976 |
Cybin Inc.
- Sector:?
- Healthcare
- Industry:? Biotechnology
- Full Time Employees:?
- 50
Description
Cybin Inc., a clinical-stage biopharmaceutical company, focuses on developing psychedelic-based therapeutics for patients with mental health conditions. The company's development pipeline includes CYB003, a deuterated psilocybin analog, which is in phase 1/2a clinical trial to treat major depressive disorder (MDD), as well as in preclinical trials for alcohol use disorder; CYB004, a deuterated dimethyltryptamine (DMT), which completed phase 2 clinical trial for treating generalized anxiety disorders; SPL028 injectable deuterated DMT completed phase 1 clinical intramuscular and intravenous trial; SPL026 completed phase 1, 1b, and 1/2a for MDD; and CYB005, a phenethylamine derivative, which in preclinical stage to treat neuroinflammation, as well as has a research pipeline of investigational psychedelic-based compounds. The company has research and collaboration agreement with TMS Neurohealth Centers Inc. for development of psychedelic compound-based therapeutics; Kernel for use of Kernel flow technology to measure neural activity; and Greenbook TMS to establish mental health centers. The company is headquartered in Toronto, Canada.
Corporate Governance
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available